Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Velastegui
K. Velastegui
Medicine
Cancer research
Nivolumab
Oncology
Internal medicine
5
Papers
81
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
99O_PR KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (Pts) with advanced non–small cell lung cancer (NSCLC) harboring KRASG12C mutation
2021
Journal of Thoracic Oncology
G. J. Riely
S-H.I. Ou
Igor I. Rybkin
Alexander I. Spira
Kyri Papadopoulos
Joshua K. Sabari
Melissa Lynne Johnson
Rebecca S. Heist
Lyudmila Bazhenova
Minal Barve
Jose M. Pacheco
K. Velastegui
C. Cilliers
Peter Olson
James G. Christensen
Thian Kheoh
Richard C. Chao
Pasi A. Jänne
Show All
Source
Cite
Save
Citations (11)
KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Advanced/ Metastatic Non–Small-Cell Lung Cancer (NSCLC) Harboring KRAS G12C Mutation
2020
European Journal of Cancer
Pasi A. Jänne
I. I. Rybkin
Alexander I. Spira
G. J. Riely
Kyri Papadopoulos
J.K. Sabari
Melissa Lynne Johnson
Rebecca S. Heist
Lyudmila Bazhenova
M. Barve
Jose M. Pacheco
T. A. Leal
K. Velastegui
C. Cornélius
P. Olson
James Christensen
T. Kheoh
R C Chao
Sai-Hong Ignatius Ou
Show All
Source
Cite
Save
Citations (43)
KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Patients with Colorectal Cancer (CRC) and Other Solid Tumors Harboring a KRAS G12C Mutation
2020
European Journal of Cancer
Melissa Lynne Johnson
Sai-Hong Ignatius Ou
M. Barve
I. I. Rybkin
Kyri Papadopoulos
T. A. Leal
K. Velastegui
James Christensen
T. Kheoh
R C Chao
J. Weiss
Show All
Source
Cite
Save
Citations (20)
PS02.08 Evidence of Clinical Activity of Sitravatinib in Combination with Nivolumab in NSCLC Patients Progressing on Prior Checkpoint Inhibitor Therapy: Topic: Medical Oncology
2017
Journal of Thoracic Oncology
T.A. Leal
Leora Horn
K. Velastegui
James Christensen
Isan Chen
Alexander I. Spira
Show All
Source
Cite
Save
Citations (4)
MA 02.01 Evidence of Clinical Activity of Sitravatinib in Combination with Nivolumab in NSCLC Patients Progressing on Prior Checkpoint Inhibitors
2017
Journal of Thoracic Oncology
Ticiana A. Leal
Toby C. Campbell
A. Mapes
K. Schneider
M.J. Staab
K. Velastegui
James Christensen
Isan Chen
Anne M. Traynor
Show All
Source
Cite
Save
Citations (3)
1